MyChesCo on MSN5d
Wistar Institute Reveals Breakthrough in DNA-LNP Vaccine Technology
A new study led by scientists at The Wistar Institute, in collaboration with the University of Pennsylvania Perelman School ...
Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology
Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...
BioSpace14d
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
INOVIO’s proprietary CELLECTRA® delivery devices are designed to optimally deliver its DNA medicines to the body’s cells without requiring chemical adjuvants or lipid nanoparticles ... and ...
C&EN15d
OPSALC: On-Particle Solvent-Assisted Lipid Coating to Create Erythrocyte Membrane-like Coatings with Improved Hemocompatibility
Department of Bioengineering Technologies, Leijten Laboratory, Faculty of Science and Technology, Technical Medical Centre, University of Twente, Drienerlolaan 5, Enschede 7522NB, The Netherlands ...
mlive16d
Still ‘no red flags’ for COVID vaccine after years of monitoring their safety
Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
The Vancouver Sun17d
Dean Regier: Canada must step up as the global leader in pandemic preparedness
From sequencing SARS-CoV-1 in 2003, to single-cell analysis for immunotherapy, to pioneering lipid nanoparticles for mRNA delivery — Canadian science set the foundation for diagnostics ...
JD Supra17d
COVID-19 Vaccine Patent War: Moderna's Claims Invalidated by PTAB
The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...
C&EN18d
Building a better COVID-19 vaccine
One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract allows for robust antibody and T-cell responses where SARS-CoV-2 generally ...